Adverse effects of gender‐affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database

MLA

Melissa Yelehe, et al. “Adverse Effects of Gender‐affirming Hormonal Therapy in Transgender Persons: Assessing Reports in the French Pharmacovigilance Database.” Fundamental & Clinical Pharmacology, vol. 36, June 2022, pp. 1115–24. EBSCOhost, https://doi.org/10.1111/fcp.12806.

APA

Melissa Yelehe, Marc Klein, Layal El Aridi, Anaïs Maurier, Pierre Gillet, & Eva Feigerlova. (2022). Adverse effects of gender‐affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database. Fundamental & Clinical Pharmacology, 36, 1115–1124. https://doi.org/10.1111/fcp.12806

Chicago

Melissa Yelehe, Marc Klein, Layal El Aridi, Anaïs Maurier, Pierre Gillet, and Eva Feigerlova. 2022. “Adverse Effects of Gender‐affirming Hormonal Therapy in Transgender Persons: Assessing Reports in the French Pharmacovigilance Database.” Fundamental & Clinical Pharmacology 36 (June): 1115–24. doi:10.1111/fcp.12806.